1Department of Chemsitry, J.C. Bose University of Science and Technology YMCA, Faridabad, India
2School of Environmental Science and Engineering, Shandong University, Jimo, Qingdao 266237, P.R. China
3VBRI, 7/16 Kalkaji Extn., New Delhi 110 019, India
4Department of Biotechnology, Jamia Hamdard University, New Delhi 110062, India
5Department of Biotechnology, Shoolini University of Biotechnology and Management Sciences, Bajhol, Solan,
Himachal Pradesh, India
6The Swiss Institute for Dryland Environmental and Energy Research, The Jacob Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Midreshet Ben-Gurion 8499000, Israel
7Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 07102, USA
Adv. Mater. Lett., 2021, 12 (2), 21021598
Publication Date (Web): Dec 14, 2020
Copyright © IAAM-VBRI Press
In current pandemic, as there is no approved specific antiviral agent for coronavirus disease (COVID-19) available till to date; Indian Ayurveda has emerged out as effective tool to control the prevailing pandemic at initial stage mainly by gearing up the immune system. Convalescent plasma therapy (CPT) has shown a glimpse of hope and some case study supported the hypothesis that CPT could be a prospective treatment option. The current study reported first time on a real time case study in India along with the outcome that CPT could be potentially improved the treatment of severe COVID-19. The CPT results presented here have shown that clinical symptoms were significantly improved along with increase of oxyhemoglobin saturation, also increased lymphocytes count whereas decreased C-reactive proteins within 3 days without any severe adverse side effect.
COVID-19 management, Convalescent plasma therapy, clinical symptoms, severe disease, treatment, clinical symptoms, pandemic health combat.